Premaitha launched its CE-marked in vitro diagnostic Iona test for noninvasive prenatal aneuploidy screening earlier this year.
Researchers used NGS to profile the tumors of metastatic colorectal carcinoma patients enrolled in the CAPRI-GOIM clinical trial.
The company is embarking on a study of up to 2,000 patients to compare its tissue-based targeted sequencing assay with its cell-free DNA test.
Researchers have created panels for ovarian hyperstimulation syndrome and to detect mutations in BCR-ABL1 gene fusions.
Diagnostic sequencing will be done on the Illumina HiSeq X Ten, the HiSeq 2500, and the NextSeq 500 in HudsonAlpha's CLIA-certified Genomics Services Laboratory.
In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.
Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.
Broken links are found throughout academic publications, and some services are trying to combat such link decay.
Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.